Skip to main content

Advertisement

SpringerLink
Log in

Surgical management of spasticity

  • Current Concept Review
  • Published:
Journal of Children's Orthopaedics

Abstract

Intractable and severe spasticity in childhood has the ability to impact on the quality of life, function and care of the child. Where medical and physical measures have proved insufficient, a surgical approach may be pursued. Irrespective of the underlying pathology, intrathecal baclofen will reduce spasticity in a controllable and reversible fashion, whereas selective dorsal rhizotomy is reserved for the management of bilateral cerebral palsy due to early birth. Owing to the potential for complications of intrathecal baclofen and the permanence of selective dorsal rhizotomy, careful selection and preparation are required to produce satisfactory results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lance JW, Burke D (1974) Mechanisms of spasticity. Arch Phys Med Rehabil 55(8):332–337

    CAS  Google Scholar 

  2. Yam WK, Leung MS (2006) Interrater reliability of Modified Ashworth Scale and Modified Tardieu Scale in children with spastic cerebral palsy. J Child Neurol 21(12):1031–1035

    Article  Google Scholar 

  3. Damiano DL, Quinlivan JM, Owen BF, Payne P, Nelson KC, Abel MF (2002) What does the Ashworth scale really measure and are instrumented measures more valid and precise? Dev Med Child Neurol 44(2):112–118

    Article  Google Scholar 

  4. Wartenberg R (1951) Pendulousness of the legs as a diagnostic test. Neurology 1(1):18–24

    Article  CAS  Google Scholar 

  5. Rekand T (2010) Clinical assessment and management of spasticity: a review. Acta Neurol Scand Suppl 190:62–66

    Article  Google Scholar 

  6. Sheean G (2002) The pathophysiology of spasticity. Eur J Neurol 9(Suppl 1):3–9; discussion 53–61

    Article  Google Scholar 

  7. Hägglund G, Wagner P (2008) Development of spasticity with age in a total population of children with cerebral palsy. BMC Musculoskelet Disord 9:150

    Article  Google Scholar 

  8. Albright AL, Barry MJ, Shafton DH, Ferson SS (2001) Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43(10):652–657

    Article  CAS  Google Scholar 

  9. Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF (1991) Intrathecal baclofen for intractable axial dystonia. Neurology 41(7):1141–1142

    Article  CAS  Google Scholar 

  10. Watve SV, Sivan M, Raza WA, Jamil FF (2012) Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord 50(2):107–111

    Article  CAS  Google Scholar 

  11. Meythaler JM, Roper JF, Brunner RC (2003) Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil 84(5):638–642

    Article  Google Scholar 

  12. Samson-Fang L, Gooch J, Norlin C (2000) Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol 42(8):561–565

    Article  CAS  Google Scholar 

  13. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87(3):409–414

    Article  CAS  Google Scholar 

  14. Albright AL, Awaad Y, Muhonen M, Boydston WR, Gilmartin R, Krach LE, Turner M, Zidek KA, Wright E, Swift D, Bloom K (2004) Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101(1 Suppl):64–68

    Google Scholar 

  15. Bennett MI, Tai YM, Symonds JM (1994) Staphylococcal meningitis following synchromed intrathecal pump implant: a case report. Pain 56(2):243–244

    Article  CAS  Google Scholar 

  16. Fjelstad AB, Hommelstad J, Sorteberg A (2009) Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 4(5):487–493

    Article  Google Scholar 

  17. Wunderlich CA, Krach LE (2006) Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study. Dev Med Child Neurol 48(6):450–455

    Article  Google Scholar 

  18. Burn SC, Zeller R, Drake JM (2010) Do baclofen pumps influence the development of scoliosis in children? J Neurosurg Pediatr 5(2):195–199

    Article  Google Scholar 

  19. Ginsburg GM, Lauder AJ (2007) Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. Spine (Phila Pa 1976) 32(24):2745–2750

    Article  Google Scholar 

  20. Sansone JM, Mann D, Noonan K, Mcleish D, Ward M, Iskandar BJ (2006) Rapid progression of scoliosis following insertion of intrathecal baclofen pump. J Pediatr Orthop 26(1):125–128

    Article  Google Scholar 

  21. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML (2004) Care provider assessment of intrathecal baclofen in children. Dev Med Child Neurol 46(8):548–552

    Article  Google Scholar 

  22. Shilt JS, Lai LP, Cabrera MN, Frino J, Smith BP (2008) The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthop 28(6):684–687

    Article  Google Scholar 

  23. Liu JK, Walker ML (2005) Posterior cervical approach for intrathecal baclofen pump insertion in children with previous spinal fusions. Technical note. J Neurosurg 102(1 Suppl):119–122

    Google Scholar 

  24. Deer TR, Raso LJ, Garten TG (2007) Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication. Pain Med 8(3):259–262

    Article  Google Scholar 

  25. McCoy AA, Fox MA, Schaubel DE, Ayyangar RN (2006) Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. Arch Phys Med Rehabil 87(11):1503–1508

    Article  Google Scholar 

  26. Steinbok P, Daneshvar H, Evans D, Kestle JR (1995) Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy. Pediatr Neurosurg 22(5):255–264; discussion 265

    Article  CAS  Google Scholar 

  27. Langerak NG, Tam N, Vaughan CL, Fieggen AG, Schwartz MH (2012) Gait status 17–26 years after selective dorsal rhizotomy. Gait Posture 35(2):244–249

    Article  Google Scholar 

  28. O’Brien DF, Park TS, Puglisi JA, Collins DR, Leuthardt EC (2004) Effect of selective dorsal rhizotomy on need for orthopedic surgery for spastic quadriplegic cerebral palsy: long-term outcome analysis in relation to age. J Neurosurg 101(1 Suppl):59–63

    Google Scholar 

  29. O’Brien DF, Park TS (2006) A review of orthopedic surgeries after selective dorsal rhizotomy. Neurosurg Focus 21(2):e2

    Google Scholar 

  30. Langerak NG, Vaughan CL, Hoffman EB, Figaji AA, Fieggen AG, Peter JC (2009) Incidence of spinal abnormalities in patients with spastic diplegia 17 to 26 years after selective dorsal rhizotomy. Childs Nerv Syst 25(12):1593–1603

    Article  Google Scholar 

  31. Golan JD, Hall JA, O’Gorman G, Poulin C, Benaroch TE, Cantin MA, Farmer JP (2007) Spinal deformities following selective dorsal rhizotomy. J Neurosurg 106(6 Suppl):441–449

    Google Scholar 

  32. Johnson MB, Goldstein L, Thomas SS, Piatt J, Aiona M, Sussman M (2004) Spinal deformity after selective dorsal rhizotomy in ambulatory patients with cerebral palsy. J Pediatr Orthop 24(5):529–536

    Article  Google Scholar 

  33. Roberts A, Stewart C, Cole G, Farmer S, Patrick J (2002) Energy consumption in spasticity. Dev Med Child Neurol 44(4):284

    Article  Google Scholar 

  34. Carroll KL, Moore KR, Stevens PM (1998) Orthopedic procedures after rhizotomy. J Pediatr Orthop 18(1):69–74

    CAS  Google Scholar 

  35. Hicdonmez T, Steinbok P, Beauchamp R, Sawatzky B (2005) Hip joint subluxation after selective dorsal rhizotomy for spastic cerebral palsy. J Neurosurg 103(1 Suppl):10–16

    Google Scholar 

  36. Cole GF, Farmer SE, Roberts A, Stewart C, Patrick JH (2007) Selective dorsal rhizotomy for children with cerebral palsy: the Oswestry experience. Arch Dis Child 92(9):781–785

    Article  CAS  Google Scholar 

  37. Davids JR, Holland WC, Sutherland DH (1993) Significance of the confusion test in cerebral palsy. J Pediatr Orthop 13(6):717–721

    Article  CAS  Google Scholar 

  38. Boyd RN, Graham HK (1999) Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 6(S4):s23–s35

    Article  Google Scholar 

  39. Butler PB, Saavedra S, Sofranac M, Jarvis SE, Woollacott MH (2010) Refinement, reliability, and validity of the segmental assessment of trunk control. Pediatr Phys Ther 22(3):246–257

    Article  Google Scholar 

  40. Fowler EG, Staudt LA, Greenberg MB, Oppenheim WL (2009) Selective Control Assessment of the Lower Extremity (SCALE): development, validation, and interrater reliability of a clinical tool for patients with cerebral palsy. Dev Med Child Neurol 51(8):607–614

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Unit, Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry, UK

    Andrew Roberts

Authors
  1. Andrew Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew Roberts.

About this article

Cite this article

Roberts, A. Surgical management of spasticity. J Child Orthop 7, 389–394 (2013). https://doi.org/10.1007/s11832-013-0512-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11832-013-0512-9

Keywords

Search

Navigation